[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.111.118. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
December 1986

Chemoprevention of Colorectal NeoplasmsAscorbic Acid and β-Carotene

Author Affiliations

From the Departments of Surgery (Dr Colacchio) and Pathology (Dr Memoli), Dartmouth-Hitchcock Medical Center, Hanover, NH.

Arch Surg. 1986;121(12):1421-1424. doi:10.1001/archsurg.1986.01400120071012
Abstract

• The organospecific, 1,2-dimethylhydrazine—induced rat tumor model was used to test tumor formation in groups of animals receiving (1) regular chow, (2) powdered chow with 7%/wt ascorbic acid supplement, (3) pelleted chow with 1%/wt β-carotene supplement, and (4) pelleted chow with placebo beadlets. Following a 16-week induction period, animals were killed and tumor formation was recorded. Tumor formation in the ascorbic acid supplement group was found to be significantly less than the control group. The β-carotene group showed no difference in tumor formation compared with the placebo-beadlet control group. Tumor incidence was generally the same between the two control groups, and the ascorbic acid group had significantly fewer tumors than the β-carotene group. In sum, ascorbic acid supplements in high doses significantly decreased tumor formation, whereas β-carotene supplements in moderately high doses had no effect on tumor formation in this model.

(Arch Surg 1986;121:1421-1424)

References
1.
Silverbury E:  Cancer statistics 1986 . CA 1986;36:19-27.
2.
Enstrom JE:  Assessing human epidemiologic data on diet as an etiologic factor in cancer development . Bull NY Acad Med 1982;58:313-322.
3.
Bruce WR, Varghesse AJ, Furrer R, et al:  A mutagen in the feces of normal humans , in Hiatt HH, Watson JD, Winston JA (eds): Origins of Human Cancer . Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1977, pp 1641-1646.
4.
McCann J, Ames BN:  Detection of carcinogens as mutagens in the salmonella/microsome test: Assay of 300 chemicals . Proc Natl Acad Sci USA 1976;73:950.Article
5.
Hendricks DG, Cornforth DP, Bartholomew DT, et al: Influence of dietary fiber and method of meat cookery upon human fecal microflora and mutagenicity of stool extracts. Read before the First Conference on Radioprotectors and Anticarcinogens, Gaithersburg, Md, June 21-24, 1982.
6.
Mower HF, Ichinotsubo D, Wang LW, et al:  Fecal mutagens in two Japanese populations with different colon cancer risks . Cancer Res 1982;42: 1164-1169.
7.
Wilkins TD, Lederman M, VanTassell AL, et al:  Characterization of a mutagenic bacterial product in human feces . Am J Clin Nutr 1980;33: 2513-2520.
8.
Colten T: Statistics in Medicine . Boston, Little, Brown & Co, 1975, pp 99-150.
9.
Wattenberg LW, Lam LKT, Loub WD, et al:  Inhibitors of chemical carcinogenesis , in Hiatt HH, Watson JD, Winsten JA (eds): Origins of Human Cancer . Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1977, pp 785-799.
10.
Soloway MS, Cohen SM, de Kernion JB, et al:  Failure of ascorbic acid to inhibit FANFT-induced bladder cancer . J Urol 1974;113:483-486.
11.
Reddy BS, Hirota N, Katayama S:  Effect of dietary sodium ascorbate on 1,2-dimethylhydrazine or methylnitrosouria induced colon carcinogenesis in rats . Carcinogenesis 1982;3:1097-1099.Article
12.
Dunham WB, Zuckerhandle E, Reynolds R, et al:  Effects of intake of L-ascorbic acid on the incidence of dermal neoplasms induced in mice by ultraviolet light . Proc Natl Acad Sci USA 1982;79:7532-7536.Article
13.
Abul-Hajj YJ, Kelliher M:  Failure of ascorbic acid to inhibit growth of transplantable and dimethylbenzanthracene induced rat mammary tumors . Cancer Lett 1982;17:67-73.Article
14.
Fukushima S, Imaida K, Sakata T, et al:  Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in rats . Cancer Res 1983;43:4454-4457.
15.
Khar'Kovaskaya NA, Khrustalev SA, Zharova EI, et al:  Effect of ascorbic acid on carcinogenicity of P-hydroxyphenylactic acid . Byull Eksp Biol Med 1982;93:64-66.
16.
Mirvish SS, Wallcave L, Eagen M, et al:  Ascorbate-nitrate reaction: Possible means of blocking the formation of N-nitroso compounds . Science 1972;177:65-68.Article
17.
Fukushima S, Hagiwara A, Ogiso T, et al:  Promoting effects of various chemicals in rat urinary bladder carcinogenesis initiated by N-nitroso-n-butyl-(4-hydroxybutyl)amine . Food Chem Toxicol 1983;21:59-68.Article
18.
Jones FE, Komorowski FA, Condon RE:  Chemoprevention of 1,2-dimethylhydrazine—induced large bowel neoplasms . Surg Forum 1981;31: 435-437.
19.
Tsuda H, Sakata T, Shirai T, et al:  Modification of MNU initiated carcinogenesis in the rat by subsequent treatment with antioxidants, phenobarbital, and ethinyl estradiol . Cancer Lett 1984;24:19-27.Article
20.
Epstein JH:  Effects of β-carotene on ultraviolet induced cancer formation in the hairless mouse skin . Photochem Photobiol 1977;25:211-213.Article
21.
Seifter E, Rettura G, Padawer J, et al:  Maloney murine sarcoma virus tumors in cba/j mice: Chemoprevention and chemotherapeutic actions of supplemental β-carotene . JNCI 1982;68:835-840.
22.
Mathews-Roth MM:  Antitumor activity of β-carotene, canthaxanthine and phytoene . Oncology 1982;39:33-37.Article
23.
Rettura G, Stratford F, Levenson SM, et al:  Prophylactic and therapeutic actions of supplemental beta-carotene in mice inoculated with C3HBA adenocarcinoma cells: Lack of therapeutic action of supplemental ascorbic acid . JNCI 1982;59:73-77.
24.
Seifter E, Rettura G, Padawer J, et al:  Regression of C3HBA mouse tumor due to X-ray therapy combined with supplemental β-carotene or vitamin A . JNCI 1983;71:409-417.
25.
Alam SQ, Alam BS:  Chemopreventive effects of β-carotene and 13-cis-retinoic acid on salivary gland tumors . Fed Proc 1983;42:1313.
×